Skip to main content
OpenTrials
Completed

NCT Number: NCT01874717

Midazolam Sedation in Dentally Anxious Patients

Use lay language.

To compare patient level of cooperation during dental care under conscious sedation with midazolam according to the administration route

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

About this study

The progress of the study is described below:

Session 1: intravenous administration of midazolam. Establishment of the individual dose.

Randomisation.

Session 2 :

Group A : oral administration of midazolam : the dose administered is twice the individual dose determined in session 1.

Group B : intravenous administration of midazolam at the individual dose determined in session 1.

Session 3 : reversal of the procedures :

Group A : intravenous administration of midazolam at the individual dose determined in session 1.

Group B : oral administration of midazolam : the dose administered is twice the individual dose determined in session 1.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • - Patient between 8 and 60 years, regardless of gender
  • Patient in the American Society of Anesthesiologists (ASA) category I ou II.
  • Patient in need of multiple dental care, referred to the Unit of Special Care Dentistry for cooperation difficulties
  • Patients directed to conscious sedation under midazolam because they cannot be approached for more than a very brief examination, or following failure to treat under inhalation sedation (50% N2O/O2), or following poor cooperation during treatment under inhalation sedation (poor cooperation is defined as a score of 3 or more on the French modified version of the Venham scale), or following good cooperation during short and simple treatment under inhalation sedation but in need of more complex rehabilitation.
  • Written consent signed by the patient or his legal guardian
  • Patient accompanied by an accountable person

Exclusion criteria

  • - Patient below 8 years or over 60 years-old
  • Patient in the American Society of Anesthesiologists (ASA) category III or more
  • Patient having accepted dental treatment without premedication or sedation, and without declaring dental anxiety, during the month prior to the appointment
  • Patient having received an anxiolytic premedication in the 24 hours preceding the dental care session
  • Patient already treated under midazolam sedation less than a week ago
  • Any medical contraindication to the use of midazolam

Treatment and study plan

Conscious sedation for dental care

Other

midazolam

Drug

Primary outcomes

  1. Patient level of cooperation which is assessed using the French modified version of Venham scale

    Time frame: At the first contact with the dentist (at day 1)

    This scale offers a good description of behaviour and anxiety in one score (from0 to 5)

  2. Patient level of cooperation which is assessed using the French modified version of Venham scale

    Time frame: During venous cannulation (at day 1)

    This scale offers a good description of behaviour and anxiety in one score (from 0 to 5)

  3. Patient level of cooperation which is assessed using the French modified version of Venham scale

    Time frame: During the first injection of local anaesthesia (at day 1)

    This scale offers a good description of behaviour and anxiety in one score (from0 to 5)

  4. Patient level of cooperation which is assessed using the French modified version of Venham scale

    Time frame: During the first dental care procedure (at day 1)

    This scale offers a good description of behaviour and anxiety in one score (from0 to 5)

Secondary outcomes

  1. The level of patient stress which is assessed using the French modified version of Venham scale

    Time frame: at T1 (first contact)

    This scale offers a good description of behaviour and anxiety in one score (from0 to 5)

  2. The level of patient stress which is assessed using the French modified version of Venham scale

    Time frame: at T8 (end of dental treatment)

    This scale offers a good description of behaviour and anxiety in one score (from0 to 5)

  3. Satisfaction level of the patient which is assessed using the French modified version of Venham scale

    Time frame: 48 hours after dental care (T14).

    This scale offers a good description of behaviour and anxiety in one score (from 0 to 5)

  4. Satisfaction level of the accompanying person which is assessed using the French modified version of Venham scale

    Time frame: 48 hours after dental care (T14).

    This scale offers a good description of behaviour and anxiety in one score (from 0 to 5)

  5. Satisfaction level of the operator which is assessed using the French modified version of Venham scale

    Time frame: 48 hours after dental care (T14).

    This scale offers a good description of behaviour and anxiety in one score (from 0 to 5)

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Registry information

Official study title

Conscious Sedation With Midazolam in Dentally Anxious Patients: Effect of the Administration Route (Oral Versus Intravenous Administration)

Important dates

Study start
2005
Primary completion
2007
Study completion
2007
First posted
Jun 11, 2013
Registry last updated
Jun 11, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.